Off-market insider buying at IM Cannabis (C:IMCC)

Marc Lustig, a Senior Officer, Director and Subsidiary Executive, acquired 102,152 Common Shares on a direct ownership basis at a price of $1.250USD through a prospectus or prospectus exempt offering on January 20th, 2023. The insider also acquired 102,152 Warrants with an exercise price of US$1.500 for 36 months. This represents a $171,373 investment into the company's shares and an account share holdings change of greater than 100%.

IM Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which held a cultivation license to breed, grow and supply medical cannabis products in Israel. It also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.